These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 19652977)
1. Monitoring of treatment response after chemoradiotherapy for head and neck cancer using in vivo 1H MR spectroscopy. King AD; Yeung DK; Yu KH; Mo FK; Hu CW; Bhatia KS; Tse GM; Vlantis AC; Wong JK; Ahuja AT Eur Radiol; 2010 Jan; 20(1):165-72. PubMed ID: 19652977 [TBL] [Abstract][Full Text] [Related]
2. In vivo 1H magnetic resonance spectroscopy of lactate in patients with stage IV head and neck squamous cell carcinoma. Le QT; Koong A; Lieskovsky YY; Narasimhan B; Graves E; Pinto H; Brown JM; Spielman D Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1151-7. PubMed ID: 18258377 [TBL] [Abstract][Full Text] [Related]
3. Pretreatment and early intratreatment prediction of clinicopathologic response of head and neck cancer to chemoradiotherapy using 1H-MRS. King AD; Yeung DK; Yu KH; Mo FK; Bhatia KS; Tse GM; Vlantis AC; Wong JK; Hu CW; Ahuja AT J Magn Reson Imaging; 2010 Jul; 32(1):199-203. PubMed ID: 20578027 [TBL] [Abstract][Full Text] [Related]
4. In vivo 1H MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements. Star-Lack JM; Adalsteinsson E; Adam MF; Terris DJ; Pinto HA; Brown JM; Spielman DM AJNR Am J Neuroradiol; 2000 Jan; 21(1):183-93. PubMed ID: 10669248 [TBL] [Abstract][Full Text] [Related]
5. In vivo characterisation of soft tissue tumours by 1.5-T proton MR spectroscopy. Russo F; Mazzetti S; Grignani G; De Rosa G; Aglietta M; Anselmetti GC; Stasi M; Regge D Eur Radiol; 2012 May; 22(5):1131-9. PubMed ID: 22138734 [TBL] [Abstract][Full Text] [Related]
6. MR spectroscopy of head and neck cancer. Abdel Razek AA; Poptani H Eur J Radiol; 2013 Jun; 82(6):982-9. PubMed ID: 23485098 [TBL] [Abstract][Full Text] [Related]
7. Proton and phosphorous MR spectroscopy in squamous cell carcinomas of the head and neck. Chawla S; Kim S; Loevner LA; Quon H; Wang S; Mutale F; Weinstein G; Delikatny EJ; Poptani H Acad Radiol; 2009 Nov; 16(11):1366-72. PubMed ID: 19608433 [TBL] [Abstract][Full Text] [Related]
8. The role of neural networks in improving the accuracy of MR spectroscopy for the diagnosis of head and neck squamous cell carcinoma. Gerstle RJ; Aylward SR; Kromhout-Schiro S; Mukherji SK AJNR Am J Neuroradiol; 2000; 21(6):1133-8. PubMed ID: 10871028 [TBL] [Abstract][Full Text] [Related]
9. Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies. Mukherji SK; Schiro S; Castillo M; Kwock L; Muller KE; Blackstock W AJNR Am J Neuroradiol; 1997; 18(6):1057-72. PubMed ID: 9194433 [TBL] [Abstract][Full Text] [Related]
10. Prediction of treatment response in head and neck cancer by magnetic resonance spectroscopy. Bezabeh T; Odlum O; Nason R; Kerr P; Sutherland D; Patel R; Smith IC AJNR Am J Neuroradiol; 2005 Sep; 26(8):2108-13. PubMed ID: 16155166 [TBL] [Abstract][Full Text] [Related]
11. In vitro proton magnetic resonance spectroscopic lactate and choline measurements, 18F-FDG uptake, and prognosis in patients with lung adenocarcinoma. Guo J; Higashi K; Yokota H; Nagao Y; Ueda Y; Kodama Y; Oguchi M; Taki S; Tonami H; Yamamoto I J Nucl Med; 2004 Aug; 45(8):1334-9. PubMed ID: 15299058 [TBL] [Abstract][Full Text] [Related]
12. Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors. Zhang J; Cheng K; Ding Y; Liang W; Ding Y; Vanel D; Cheng X Eur J Radiol; 2013 Dec; 82(12):2124-8. PubMed ID: 22169357 [TBL] [Abstract][Full Text] [Related]
13. MRI and (1)H MRS of the breast: presence of a choline peak as malignancy marker is related to K21 value of the tumor in patients with invasive ductal carcinoma. Geraghty PR; van den Bosch MA; Spielman DM; Hunjan S; Birdwell RL; Fong KJ; Stables LA; Zakhour M; Herfkens RJ; Ikeda DM Breast J; 2008; 14(6):574-80. PubMed ID: 19000051 [TBL] [Abstract][Full Text] [Related]
14. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. Reinsberg SA; Payne GS; Riches SF; Ashley S; Brewster JM; Morgan VA; deSouza NM AJR Am J Roentgenol; 2007 Jan; 188(1):91-8. PubMed ID: 17179350 [TBL] [Abstract][Full Text] [Related]
15. Can magnetic resonance spectroscopy differentiate endometrial cancer? Zhang J; Cai S; Li C; Sun X; Han X; Yang C; Fu C; Liu Q; Xin Y; Zong Y Eur Radiol; 2014 Oct; 24(10):2552-60. PubMed ID: 24903228 [TBL] [Abstract][Full Text] [Related]
16. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors. Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615 [TBL] [Abstract][Full Text] [Related]
17. 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation. Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX Eur J Radiol; 2010 Feb; 73(2):345-51. PubMed ID: 19070978 [TBL] [Abstract][Full Text] [Related]
18. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas. Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868 [TBL] [Abstract][Full Text] [Related]
19. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2. Gao W; Wang X; Li F; Shi W; Li H; Zeng Q Acta Radiol; 2019 Jan; 60(1):106-112. PubMed ID: 29665708 [TBL] [Abstract][Full Text] [Related]
20. Cerebral blood volume measurements and proton MR spectroscopy in grading of oligodendroglial tumors. Spampinato MV; Smith JK; Kwock L; Ewend M; Grimme JD; Camacho DL; Castillo M AJR Am J Roentgenol; 2007 Jan; 188(1):204-12. PubMed ID: 17179366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]